351 related articles for article (PubMed ID: 11900492)
1. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1.
Drissi H; Pouliot A; Stein JL; van Wijnen AJ; Stein GS; Lian JB
J Cell Biochem; 2002; 86(2):403-12. PubMed ID: 12112009
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.
Kitazawa S; Kajimoto K; Kondo T; Kitazawa R
J Cell Biochem; 2003 Jul; 89(4):771-7. PubMed ID: 12858342
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene.
Drissi H; Luc Q; Shakoori R; Chuva De Sousa Lopes S; Choi JY; Terry A; Hu M; Jones S; Neil JC; Lian JB; Stein JL; Van Wijnen AJ; Stein GS
J Cell Physiol; 2000 Sep; 184(3):341-50. PubMed ID: 10911365
[TBL] [Abstract][Full Text] [Related]
5. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
Viereck V; Siggelkow H; Tauber S; Raddatz D; Schutze N; Hüfner M
J Cell Biochem; 2002; 86(2):348-56. PubMed ID: 12112004
[TBL] [Abstract][Full Text] [Related]
7. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
[TBL] [Abstract][Full Text] [Related]
8. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
10. Variations in vitamin D receptor transcription factor complexes associated with the osteocalcin gene vitamin D responsive element in osteoblasts and osteosarcoma cells.
Shakoori AR; van Wijnen AJ; Bortell R; Owen TA; Stein JL; Lian JB; Stein GS
J Cell Biochem; 1994 Jun; 55(2):218-29. PubMed ID: 8089197
[TBL] [Abstract][Full Text] [Related]
11. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
[TBL] [Abstract][Full Text] [Related]
12. Analysis of regulatory regions in the COL1A1 gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression in osteoblastic cells.
Pavlin D; Bedalov A; Kronenberg MS; Kream BE; Rowe DW; Smith CL; Pike JW; Lichtler AC
J Cell Biochem; 1994 Dec; 56(4):490-501. PubMed ID: 7890807
[TBL] [Abstract][Full Text] [Related]
13. Translational regulation is a control point in RUNX2/Cbfa1 gene expression.
Sudhakar S; Li Y; Katz MS; Elango N
Biochem Biophys Res Commun; 2001 Nov; 289(2):616-22. PubMed ID: 11716520
[TBL] [Abstract][Full Text] [Related]
14. Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells.
Thirunavukkarasu K; Halladay DL; Miles RR; Geringer CD; Onyia JE
J Cell Biochem; 2002; 85(4):837-50. PubMed ID: 11968023
[TBL] [Abstract][Full Text] [Related]
15. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.
Nayeri S; Danielsson C; Kahlen JP; Schräder M; Mathiasen IS; Binderup L; Carlberg C
Oncogene; 1995 Nov; 11(9):1853-8. PubMed ID: 7478614
[TBL] [Abstract][Full Text] [Related]
16. Modulation of TNF-alpha expression in bone marrow macrophages: involvement of vitamin D response element.
Hakim I; Bar-Shavit Z
J Cell Biochem; 2003 Apr; 88(5):986-98. PubMed ID: 12616536
[TBL] [Abstract][Full Text] [Related]
17. Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene.
Fen JQ; Zhang J; Dallas SL; Lu Y; Chen S; Tan X; Owen M; Harris SE; MacDougall M
J Bone Miner Res; 2002 Oct; 17(10):1822-31. PubMed ID: 12369786
[TBL] [Abstract][Full Text] [Related]
18. Human estrogen receptor alpha gene is a target of Runx2 transcription factor in osteoblasts.
Lambertini E; Penolazzi L; Tavanti E; Schincaglia GP; Zennaro M; Gambari R; Piva R
Exp Cell Res; 2007 May; 313(8):1548-60. PubMed ID: 17350616
[TBL] [Abstract][Full Text] [Related]
19. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
20. Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation.
Napierala D; Garcia-Rojas X; Sam K; Wakui K; Chen C; Mendoza-Londono R; Zhou G; Zheng Q; Lee B
Mol Genet Metab; 2005; 86(1-2):257-68. PubMed ID: 16140555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
